This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Assia Chemical Industries Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Andrea Szilagyi: Innovator in Pharmaceutical Chemistry
Introduction
Andrea Szilagyi is a prominent inventor based in Debrecen, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of solid-state forms of Venetoclax. Her work has implications for the treatment of various medical conditions, showcasing her dedication to advancing healthcare through innovation.
Latest Patents
Andrea Szilagyi holds a patent for "Solid state forms of Venetoclax and processes for preparation of Venetoclax." This patent discloses processes for the preparation of Venetoclax and the Venetoclax produced by these processes. Additionally, it includes intermediate compounds used in the processes, specifically highlighting the compound of formula 5. This innovation is crucial for enhancing the efficacy and stability of Venetoclax in pharmaceutical applications.
Career Highlights
Andrea is associated with Assia Chemical Industries Ltd., where she applies her expertise in pharmaceutical development. Her role at the company allows her to collaborate with other talented professionals in the field, contributing to the advancement of chemical processes and formulations.
Collaborations
Andrea has worked alongside notable colleagues, including Zsuzsa Potarine Juhasz and Szabolcs Struba. These collaborations have fostered a productive environment for innovation and research, further enhancing the impact of their collective work in the industry.
Conclusion
Andrea Szilagyi's contributions to pharmaceutical chemistry, particularly through her patent on Venetoclax, highlight her role as an influential inventor. Her work not only advances scientific knowledge but also has the potential to improve patient outcomes in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile